Litigation Details for Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. (D. Del. 2017)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. (D. Del. 2017)
| Docket | ⤷ Try a Trial | Date Filed | 2017-04-07 |
| Court | District Court, D. Delaware | Date Terminated | 2019-01-01 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Parties | MYLAN PHARMACEUTICALS INC. | ||
| Patents | 7,297,703; 8,617,598; 8,778,962 | ||
| Attorneys | Daniel M. Silver | ||
| Firms | Young, Conaway, Stargatt & Taylor LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-01-02 | 100 | ,778,962; 8,617,598; US 7,297,703 B2. (Attachments: # 1 Order)(nms) (Entered: 01/03/2019) 3 January… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,665,772; 8,778,962…2017 2 January 2019 1:17-cv-00389 830 Patent None District Court, D. Delaware | External link to document | |
| 2017-04-07 | 3 | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,665,772; 8,778,962; 8,617,598. (crb) (…2017 2 January 2019 1:17-cv-00389 830 Patent None District Court, D. Delaware | External link to document | |
| 2017-11-06 | 37 | (1) Novartiss Infringement Chart for U.S. Patent 7,297,703, (2) Novartiss First Set of Requests for Production…2017 2 January 2019 1:17-cv-00389 830 Patent None District Court, D. Delaware | External link to document | |
| 2018-03-12 | 47 | Supplemental Infringement Chart Concerning U.S. Patent No. 8,617,598 filed by Novartis AG, Novartis Pharmaceuticals…2017 2 January 2019 1:17-cv-00389 830 Patent None District Court, D. Delaware | External link to document | |
| 2018-06-29 | 72 | Opinion - Memorandum Opinion | quot;the ' 598 patent"), and 7,297,703 ("the ' 703 patent"). I held oral argument…for multiple terms in U.S. Patent Nos. 8,778,962, 8,617,598, and 7,297,703. Within five days the parties…of multiple terms in U.S. Patent Nos. 8,778,962 ("the ' 962 patent"), 8,617,598 ("…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which …construing patent claims, a court considers the literal language of the claim, the patent specification | External link to document |
| 2018-09-24 | 85 | M. Klibanov on the Infringement of U.S. Patent No. 8,617,598 By Defendant Mylan Pharmaceuticals Inc.;…William R. Roush Regarding Infringement Of U.S. Patent No. 5,665,772; (2) Opening Expert Report of Professor…Ess, M.D., Ph.D. Regarding Infringement of U.S. Patent No. 8,778,962 filed by Novartis AG, Novartis Pharmaceuticals…2017 2 January 2019 1:17-cv-00389 830 Patent None District Court, D. Delaware | External link to document | |
| 2018-10-24 | 87 | Klibanov Concerning the Validity of U.S. Patent No. 8,617,598 (Confidential); and (2) Responsive Expert…Ess, M.D., Ph.D. Regarding the Validity of U.S. Patent No. 8,778,962 filed by Novartis AG, Novartis Pharmaceuticals…2017 2 January 2019 1:17-cv-00389 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
